Published in Appl Environ Microbiol on July 01, 2004
Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens. Appl Environ Microbiol (2005) 2.04
Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol (2009) 2.01
Bacteriophage therapy to reduce salmonella colonization of broiler chickens. Appl Environ Microbiol (2007) 1.64
Campylobacter jejuni multilocus sequence types in humans, northwest England, 2003-2004. Emerg Infect Dis (2006) 1.45
A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome. Eur J Clin Microbiol Infect Dis (2012) 1.24
Enumeration and diversity of campylobacters and bacteriophages isolated during the rearing cycles of free-range and organic chickens. Appl Environ Microbiol (2005) 1.23
The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens. BMC Microbiol (2010) 1.19
Phase variable expression of capsular polysaccharide modifications allows Campylobacter jejuni to avoid bacteriophage infection in chickens. Front Cell Infect Microbiol (2012) 1.18
Bacteriophage F336 recognizes the capsular phosphoramidate modification of Campylobacter jejuni NCTC11168. J Bacteriol (2011) 1.17
Phase-variable surface structures are required for infection of Campylobacter jejuni by bacteriophages. Appl Environ Microbiol (2006) 1.11
Characterization of Campylobacter phages including analysis of host range by selected Campylobacter Penner serotypes. BMC Microbiol (2007) 1.05
Genome and proteome of Campylobacter jejuni bacteriophage NCTC 12673. Appl Environ Microbiol (2011) 1.01
Campylobacter jejuni group III phage CP81 contains many T4-like genes without belonging to the T4-type phage group: implications for the evolution of T4 phages. J Virol (2011) 1.00
Effect of bacteriophage application on Campylobacter jejuni loads in commercial broiler flocks. Appl Environ Microbiol (2013) 0.98
Correlation of Campylobacter bacteriophage with reduced presence of hosts in broiler chicken ceca. Appl Environ Microbiol (2005) 0.98
Bacteriophage-Mediated Dispersal of Campylobacter jejuni Biofilms. Appl Environ Microbiol (2011) 0.88
Primary isolation strain determines both phage type and receptors recognised by Campylobacter jejuni bacteriophages. PLoS One (2015) 0.87
Complete Genome Sequence of Universal Bacteriophage Host Strain Campylobacter jejuni subsp. jejuni PT14. Genome Announc (2013) 0.85
Alternative bacteriophage life cycles: the carrier state of Campylobacter jejuni. Open Biol (2014) 0.84
Impact of a single phage and a phage cocktail application in broilers on reduction of Campylobacter jejuni and development of resistance. PLoS One (2013) 0.84
Microplate-test for the rapid determination of bacteriophage-susceptibility of Campylobacter isolates-development and validation. PLoS One (2013) 0.84
The ability of flagellum-specific Proteus vulgaris bacteriophage PV22 to interact with Campylobacter jejuni flagella in culture. Virol J (2006) 0.82
Colonisation of a phage susceptible Campylobacter jejuni population in two phage positive broiler flocks. PLoS One (2014) 0.76
Current and Potential Treatments for Reducing Campylobacter Colonization in Animal Hosts and Disease in Humans. Front Microbiol (2017) 0.75
Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine. Sci Rep (2016) 0.75
Campylobacter group II phage CP21 is the prototype of a new subgroup revealing a distinct modular genome organization and host specificity. BMC Genomics (2015) 0.75
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05
Multilocus sequence typing system for Campylobacter jejuni. J Clin Microbiol (2001) 10.17
Evolutionary relationships among diverse bacteriophages and prophages: all the world's a phage. Proc Natl Acad Sci U S A (1999) 7.05
Genotyping of Campylobacter spp. Appl Environ Microbiol (2000) 4.78
Rapid pulsed-field gel electrophoresis protocol for subtyping of Campylobacter jejuni. J Clin Microbiol (2001) 3.81
Sources of Campylobacter colonization in broiler chickens. Appl Environ Microbiol (2003) 3.17
Evidence of genomic instability in Campylobacter jejuni isolated from poultry. Appl Environ Microbiol (1998) 3.01
Serotyping scheme for Campylobacter jejuni and Campylobacter coli based on direct agglutination of heat-stable antigens. J Clin Microbiol (1998) 2.14
Phage typing of Campylobacter jejuni and Campylobacter coli and its use as an adjunct to serotyping. Epidemiol Infect (1999) 2.03
Bacteriophage therapy. Stalin's forgotten cure. Science (2002) 1.93
Generation of Campylobacter jejuni genetic diversity in vivo. Mol Microbiol (2002) 1.88
Poultry as a source of Campylobacter and related organisms. Symp Ser Soc Appl Microbiol (2001) 1.87
A longitudinal study of campylobacter infection of broiler flocks in Great Britain. Prev Vet Med (2000) 1.71
Colonization of broiler chickens by waterborne Campylobacter jejuni. Appl Environ Microbiol (1993) 1.67
Application of host-specific bacteriophages to the surface of chicken skin leads to a reduction in recovery of Campylobacter jejuni. Appl Environ Microbiol (2003) 1.64
The species concept and its application to tailed phages. Arch Virol (1992) 1.45
Isolation and characterization of Campylobacter bacteriophages from retail poultry. Appl Environ Microbiol (2003) 1.44
Characterisation of 16 Campylobacter jejuni and C. coli typing bacteriophages. J Med Microbiol (1998) 1.40
Effect of Campylobacter-specific maternal antibodies on Campylobacter jejuni colonization in young chickens. Appl Environ Microbiol (2003) 1.39
Epidemiological study of Campylobacter spp. in broilers: source, time of colonization, and prevalence. Avian Dis (1998) 1.35
Molecular subtype analyses of Campylobacter spp. from Arkansas and California poultry operations. Appl Environ Microbiol (2002) 1.34
Genomic relatedness within five common Finnish Campylobacter jejuni pulsed-field gel electrophoresis genotypes studied by amplified fragment length polymorphism analysis, ribotyping, and serotyping. Appl Environ Microbiol (2001) 1.20
Extended phage-typing scheme for Campylobacter jejuni and Campylobacter coli. Epidemiol Infect (1992) 1.18
Evidence that certain clones of Campylobacter jejuni persist during successive broiler flock rotations. Appl Environ Microbiol (2001) 1.13
Identification of a new source of Campylobacter contamination in poultry: transmission from breeder hens to broiler chickens. Avian Dis (2002) 1.11
The carry-over of Campylobacter isolates between sequential poultry flocks. Avian Dis (2002) 1.04
Isolation of Campylobacter spp. from semen samples of commercial broiler breeder roosters. Avian Dis (2002) 0.90
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
Guidelines for human gene nomenclature (1997). HUGO Nomenclature Committee. Genomics (1997) 6.44
Prevention of falls in the elderly trial (PROFET): a randomised controlled trial. Lancet (1999) 5.37
Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 4.26
Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell (1994) 4.26
An essential role in liver development for transcription factor XBP-1. Genes Dev (2000) 4.17
Transmission through the female line of a mechanism constraining human fetal growth. Int J Epidemiol (2008) 3.42
Agency in health care. Examining patients' preferences for attributes of the doctor-patient relationship. J Health Econ (1998) 2.80
Prophylactic oral antimicrobial agents in elective colonic surgery. A controlled trial. Lancet (1975) 2.72
Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity. Cell (1992) 2.62
Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell (1985) 2.59
Improving outcomes for young people with diabetes: use of new technology and a skills-based training approach is urgently needed. Diabet Med (2001) 2.35
Changing clinicians' behavior: a randomized controlled trial of fees and education. J Dent Res (2008) 2.34
National cancer registration: an appraisal. Community Med (1983) 2.29
Retrospective review of care and outcomes in young adults with type 1 diabetes. BMJ (2003) 2.22
Alzheimer's disease, other dementias, depression and pseudodementia: prevalence, incidence and three-year outcome in Liverpool. Br J Psychiatry (1992) 2.20
Automatic external defibrillators--time for a change? Br Dent J (2005) 2.18
Complications of diuretic therapy in hepatic cirrhosis. Lancet (1966) 2.09
Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens. Appl Environ Microbiol (2005) 2.04
Effect of p15-associated protease from an avian RNA tumor virus on avian virus-specific polyprotein precursors. J Virol (1980) 1.94
Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet (1991) 1.87
Preventable in-hospital medical injury under the "no fault" system in New Zealand. Qual Saf Health Care (2003) 1.84
Private costs associated with abdominal aortic aneurysm screening: the importance of private travel and time costs. J Med Screen (1995) 1.80
Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Ann Epidemiol (2000) 1.79
The genetic aetiology of Silver-Russell syndrome. J Med Genet (2007) 1.78
Abrogation of IL-3 and IL-2 dependence by recombinant murine retroviruses expressing v-myc oncogenes. Nature (1985) 1.77
The nature of the oscillatory behaviour in electrical activity from pancreatic beta-cell. Horm Metab Res Suppl (1980) 1.76
Head circumference charts updated. Arch Dis Child (1985) 1.69
MEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinase. Proc Natl Acad Sci U S A (1995) 1.65
Adverse events regional feasibility study: methodological results. N Z Med J (2001) 1.61
A large pheromone and receptor gene complex determines multiple B mating type specificities in Coprinus cinereus. Genetics (1998) 1.58
Immunological sex differences. A study of patients with rheumatoid arthritis, their relatives, and controls. Ann Rheum Dis (1969) 1.58
Genetic epidemiology study of idiopathic talipes equinovarus. Am J Med Genet (1998) 1.57
Elevated placental expression of the imprinted PHLDA2 gene is associated with low birth weight. J Mol Med (Berl) (2006) 1.53
Congenital anterior abdominal wall defects in the north of England, 1986-1996: occurrence and outcome. Prenat Diagn (1999) 1.52
Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action. Circ Res (1991) 1.51
Bacillus subtilis genes for the utilization of sulfur from aliphatic sulfonates. Microbiology (1998) 1.50
The sizes and characteristics of the minority ethnic populations of Great Britain--latest estimates. Popul Trends (2001) 1.48
Activation of mitogen-activated protein kinase cascades by p21-activated protein kinases in cell-free extracts of Xenopus oocytes. J Biol Chem (1995) 1.45
Adverse events regional feasibility study: indicative findings. N Z Med J (2001) 1.43
Swarming of Proteus--a solution to an old problem? Nature (1966) 1.41
Role and therapeutic potential of PI3K-mTOR signaling in de novo resistance to BRAF inhibition. Pigment Cell Melanoma Res (2012) 1.41
A New Zealand code of ethics. N Z Med J (1991) 1.39
In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation. J Immunother (2001) 1.38
From genome to vaccine: in silico predictions, ex vivo verification. Vaccine (2001) 1.37
Transmission through the female line of a mechanism constraining human fetal growth. Ann Hum Biol (1986) 1.36
The prevalence of dementia, depression and neurosis in later life: the Liverpool MRC-ALPHA Study. Int J Epidemiol (1993) 1.34
A bovine papilloma virus vector with a dominant resistance marker replicates extrachromosomally in mouse and E. coli cells. EMBO J (1983) 1.33
Segregation analysis of idiopathic talipes equinovarus in a Texan population. Am J Med Genet (1998) 1.32
High level expression of active human alpha-1-antitrypsin in the milk of transgenic sheep. Biotechnology (N Y) (1991) 1.32
Premeiotic disruption of duplicated and triplicated copies of the Neurospora crassa am (glutamate dehydrogenase) gene. Curr Genet (1989) 1.32
Congenital anterior abdominal wall defects. Authors' figures for Northern region are underestimates. BMJ (1997) 1.30
Campylobacter bacteriophages and bacteriophage therapy. J Appl Microbiol (2011) 1.29
Mechanotherapy: how physical therapists' prescription of exercise promotes tissue repair. Br J Sports Med (2009) 1.29
The highly conserved skb1 gene encodes a protein that interacts with Shk1, a fission yeast Ste20/PAK homolog. Proc Natl Acad Sci U S A (1996) 1.28
Measuring progress towards a primary care-led NHS. Br J Gen Pract (1999) 1.28
The Medicaid eligibility expansions for pregnant women: evaluating the strength of state implementation efforts. Fam Plann Perspect (1994) 1.27
Growth in the first four years: I. The relative effects of gender and weight for gestational age at birth. Early Hum Dev (1982) 1.27
A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci (1985) 1.26
Respiratory symptoms and pulmonary function in welders. Ann Occup Hyg (1969) 1.24
Enumeration and diversity of campylobacters and bacteriophages isolated during the rearing cycles of free-range and organic chickens. Appl Environ Microbiol (2005) 1.23
Prevalence of dementia and depression among elderly people in black and ethnic minorities. Br J Psychiatry (1997) 1.22
Consultants in nhs scotland: a survey of work commitments, remuneration, job satisfaction and retirement plans. Scott Med J (2004) 1.22
The isolation of avian viral RNA and polypeptides. J Biol Chem (1979) 1.21
Functional classification of the microbial feruloyl esterases. Appl Microbiol Biotechnol (2003) 1.19
Hand strength and dexterity. Am J Occup Ther (1971) 1.19
Use of geographic and genotyping tools to characterise tuberculosis transmission in Montreal. Int J Tuberc Lung Dis (2007) 1.18
The relative contributions of different maternal factors in small-for-gestational-age pregnancies. Eur J Obstet Gynecol Reprod Biol (1981) 1.17
Job satisfaction, work-related stress and intentions to quit of Scottish GPS. Scott Med J (2002) 1.17
Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement. Drug Alcohol Depend (2005) 1.16
The "supply hypothesis" and medical practice variation in primary care: testing economic and clinical models of inter-practitioner variation. Soc Sci Med (2000) 1.16
The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens (1999) 1.15
Health risk appraisal for older people in general practice using an expert system: a pilot study. Health Soc Care Community (2005) 1.13
Associations among pathogenic bacteria, parasites, and environmental and land use factors in multiple mixed-use watersheds. Water Res (2011) 1.10
New NICE guideline to improve outcomes for hip fracture patients. Injury (2011) 1.09
Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation (1990) 1.08
Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol (2001) 1.08
Regulation of the MAP kinase cascade. Cell Mol Biol Res (1994) 1.08
Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. J Pharmacol Exp Ther (1988) 1.07
Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. Clin Chem (1992) 1.07
Noise-induced stress as a predictor of burnout in critical care nurses. Heart Lung (1988) 1.06
Occurrence of campylobacters in small domestic and laboratory animals. J Appl Bacteriol (1993) 1.06
Recombinant pro-regions from papain and papaya proteinase IV-are selective high affinity inhibitors of the mature papaya enzymes. Protein Eng (1995) 1.04
Conventional or laparoscopic inguinal hernia repair? The surgeon's choice. Ann R Coll Surg Engl (1999) 1.04
Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes. J Hum Nutr Diet (2002) 1.04
Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes. Cell Motil Cytoskeleton (2001) 1.04
Support of thyroxine-induced swelling of liver mitochondria by generation of high energy intermediates at any one of three sites in electron transport. J Biol Chem (1966) 1.04
Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review. Am J Clin Pathol (2001) 1.03
Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial. Drugs Aging (2001) 1.03
Breakdown limits on Gigavolt-per-meter electron-beam-driven wakefields in dielectric structures. Phys Rev Lett (2008) 1.03
Cooling dissociates glucose-induced insulin release from electrical activity and cation fluxes in rodent pancreatic islets. J Physiol (1984) 1.03
Measurement of d sigma/dM and forward-backward charge asymmetry for high-mass Drell-Yan e(+)e(-) pairs from pp macro collisions at square root of s = 1.8 TeV. Phys Rev Lett (2001) 1.02
The costs of caring for stroke patients in a GP-led community hospital: an application of programme budgeting and marginal analysis. Health Soc Care Community (2001) 1.02
A practical approach to incidental findings in neuroimaging research. Neurology (2011) 1.02
An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet (2000) 1.02
Vibrio cholerae serogroup 0139 in England and Wales. BMJ (1993) 1.00
Sudden infant death in Scotland. BMJ (1993) 1.00